Status:
COMPLETED
Sarcopenia and Mechanical Ventilation in Older Patients Admitted Due to COVID-19
Lead Sponsor:
Brugmann University Hospital
Conditions:
Sarcopenia
Eligibility:
All Genders
60+ years
Brief Summary
The SarcoV study aims at assessing the association between sarcopenia and the indication of mechanical ventilation in older hospitalized patients due to COVID-19 infection
Detailed Description
Sarcopenia is disease associated with poor clinical outcomes. In critical ill chirurgical patients, sarcopenia is associated with difficult to wean of mechanical ventilation. The association between s...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Consecutive patients aged 60 and older
- Admission in an acute care unit in Brugmann university hospital due to a COVID-19 possible or confirmed infection. A infection was considered confirmed in presence of a positive molecular test by Polymerase-chain reaction (PCR), following the Belgian Public Health Department recommendations (Sciensano recommendations).
- Exclusion criteria
- Patients unable to perform a grip-strength measurement due to any rheumatological or neurological condition.
Exclusion
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 20 2021
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04772586
Start Date
September 1 2020
End Date
August 20 2021
Last Update
April 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brugmann university hospital
Brussels, Belgium, 1020